Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published online as doi:10.1189/jlb.0204113 on September 10, 2004

Published online before print September 10, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0204113v1
76/6/1207    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hansson, M.
Right arrow Articles by Hellstrand, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hansson, M.
Right arrow Articles by Hellstrand, K.
(Journal of Leukocyte Biology. 2004;76:1207-1213.)
© 2004 by Society for Leukocyte Biology

Activation of cytotoxic lymphocytes by interferon-{alpha}: role of oxygen radical-producing mononuclear phagocytes

Markus Hansson*, Ana Romero{dagger}, Fredrik Thorén{dagger}, Svante Hermodsson{dagger} and Kristoffer Hellstrand{dagger},1

* Department of Hematology, University of Lund, Sweden; and
{dagger} Department of Virology, University of Göteborg, Sweden

1 Correspondence: Department of Virology, University of Göteborg, S-413 46 Göteborg, Sweden. E-mail: kristoffer.hellstrand{at}microbio.gu.se

A significant part of the therapeutic benefit of interferon-{alpha} (IFN-{alpha}) therapy in malignant diseases and in chronic viral infections is assumed to result from activation of lymphocytes with natural killer (NK) and T cell phenotype. In tumor tissue and in chronically infected tissue, the function and viability of these lymphocytes are frequently impaired. Mononuclear phagocyte (MP)-derived reactive oxygen species (ROS) have been proposed to contribute to the lymphocyte suppression in these tissues. Here, we report that three types of human cytotoxic lymphocytes of relevance to immunoactivation by IFN-{alpha}, CD3{varepsilon}+/8+/56 T cells, CD3{varepsilon}/56+ NK cells, and CD3{varepsilon}+/56+ NK/T cells became anergic to IFN-{alpha} induction of the cell-surface activation marker CD69 after exposure to autologous MPs in vitro. In addition to their incapacity to express CD69, cytotoxic lymphocytes acquired features characteristic of apoptosis after incubation with MPs. The lymphocyte apoptosis and nonresponsiveness to IFN-{alpha} were prevented by two inhibitors of reduced nicotinamide adenine dinucleotide phosphate oxidase-dependent formation of ROS in MPs, histamine dihydrochloride and diphenylene ionodonium, as well as by catalase, a scavenger of ROS. We conclude that MP-derived ROS may negatively affect IFN-{alpha}-induced immunostimulation and propose that ROS inhibitors or scavengers may be useful to improve lymphocyte activation during treatment with IFN-{alpha}.

Key Words: T cell • NK cell • NK/T cell • histamine • ROS • CD69




This article has been cited by other articles:


Home page
CVIHome page
T. Itou, L. V. Collins, F. B. Thoren, C. Dahlgren, and A. Karlsson
Changes in Activation States of Murine Polymorphonuclear Leukocytes (PMN) during Inflammation: a Comparison of Bone Marrow and Peritoneal Exudate PMN.
Clin. Vaccine Immunol., May 1, 2006; 13(5): 575 - 583.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Mocellin, F. M. Marincola, and H. A. Young
Interleukin-10 and the immune response against cancer: a counterpoint
J. Leukoc. Biol., November 1, 2005; 78(5): 1043 - 1051.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society for Leukocyte Biology.